EXAS – Exact Sciences Corporation

Exact Sciences Corporation

EXAS

$49.26

Name : Exact Sciences Corporation

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $9,150,290,944.00

EPSttm : -5.59

Exact Sciences Corporation

$49.26

0.50%

$0.25

Float Short %

5.45

Margin Of Safety %

-12

Put/Call OI Ratio

0.58

EPS Next Q Diff

0.11

EPS Last/This Y

EPS This/Next Y

1.07

Price

49.25

Target Price

71.62

Analyst Recom

1.44

Performance Q

-0.57

Relative Volume

1.54

Beta

1.23

Ticker: EXAS

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-24	EXAS	56	0.76	0.02	39182
2025-01-27	EXAS	55.68	0.69	0.13	41729
2025-01-28	EXAS	55.38	0.68	0.83	42093
2025-01-29	EXAS	55.05	0.68	0.98	42095
2025-01-30	EXAS	56.04	0.68	0.84	42268
2025-01-31	EXAS	56.03	0.68	0.34	42365
2025-02-03	EXAS	55.27	0.66	0.64	43474
2025-02-04	EXAS	54.78	0.65	0.32	43650
2025-02-05	EXAS	55.68	0.65	0.30	43722
2025-02-06	EXAS	54.25	0.65	1.45	43775
2025-02-07	EXAS	53.5	0.66	0.11	43874
2025-02-10	EXAS	52.54	0.65	1.27	44105
2025-02-11	EXAS	50.94	0.65	0.70	44357
2025-02-12	EXAS	50.31	0.65	0.70	44634
2025-02-13	EXAS	50.56	0.66	0.52	44938
2025-02-14	EXAS	49.28	0.65	0.36	45575
2025-02-18	EXAS	49.61	0.66	0.86	46544
2025-02-19	EXAS	50.41	0.66	0.25	47437
2025-02-20	EXAS	49.3	0.63	0.38	52401
2025-02-21	EXAS	49.25	0.58	3.07	53576
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-24	EXAS	55.93	56.5	130.7	-0.56
2025-01-27	EXAS	55.70	56.5	131.5	-0.56
2025-01-28	EXAS	55.35	56.5	131.6	-0.56
2025-01-29	EXAS	54.90	56.5	131.7	-0.56
2025-01-30	EXAS	56.03	56.5	130.4	-0.56
2025-01-31	EXAS	56.04	56.5	131.3	-0.56
2025-02-03	EXAS	55.24	56.5	131.9	-0.56
2025-02-04	EXAS	54.75	56.5	131.7	-0.56
2025-02-05	EXAS	55.49	56.5	130.7	-0.56
2025-02-06	EXAS	54.28	56.5	132.4	-0.56
2025-02-07	EXAS	53.52	56.5	131.9	-0.56
2025-02-10	EXAS	52.38	56.5	132.2	-0.56
2025-02-11	EXAS	51.12	56.5	132.3	-0.56
2025-02-12	EXAS	50.33	56.5	131.9	-0.56
2025-02-13	EXAS	50.58	56.5	131.1	-0.56
2025-02-14	EXAS	49.31	56.5	132.4	-0.56
2025-02-18	EXAS	49.61	56.5	131.1	-0.56
2025-02-19	EXAS	50.48	56.5	130.6	-0.56
2025-02-20	EXAS	49.53	56.5	131.9	-0.56
2025-02-21	EXAS	49.25	77.3	955.4	0.20
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-24	EXAS	0.67	3.41	5.86
2025-01-27	EXAS	0.67	3.39	5.86
2025-01-28	EXAS	0.67	3.39	5.64
2025-01-29	EXAS	0.67	3.39	5.64
2025-01-30	EXAS	0.67	3.39	5.64
2025-01-31	EXAS	0.67	3.39	5.64
2025-02-03	EXAS	0.67	2.80	5.64
2025-02-04	EXAS	0.67	2.80	5.64
2025-02-05	EXAS	0.67	2.80	5.64
2025-02-06	EXAS	0.67	2.80	5.64
2025-02-07	EXAS	0.67	2.80	5.64
2025-02-10	EXAS	0.67	2.16	5.64
2025-02-11	EXAS	0.63	2.16	5.65
2025-02-12	EXAS	0.63	2.16	5.45
2025-02-13	EXAS	0.67	2.16	5.44
2025-02-14	EXAS	0.67	2.16	5.44
2025-02-18	EXAS	0.67	1.01	5.45
2025-02-19	EXAS	0.59	1.01	5.45
2025-02-20	EXAS	0.59	1.01	5.45
2025-02-21	EXAS	0.59	1.01	5.45
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.06

Avg. EPS Est. Current Quarter

-0.12

Avg. EPS Est. Next Quarter

0.05

Insider Transactions

0.59

Institutional Transactions

1.01

Beta

1.23

Average Sales Estimate Current Quarter

690

Average Sales Estimate Next Quarter

757

Fair Value

43.34

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

69.1

Max Drawdown 5-Year %

-80.4

Target Price

71.62

P/E

Forward P/E

70.93

PEG

P/S

3.32

P/B

2.84

P/Free Cash Flow

92.96

EPS

-5.56

Average EPS Est. Cur. Y

0.2

EPS Next Y. (Est.)

1.27

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-37.29

Relative Volume

1.54

Return on Equity vs Sector %

-62.1

Return on Equity vs Industry %

-53.3

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.2

EBIT Estimation

955.4

Exact Sciences Corporation

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 6900

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

stock quote shares EXAS – Exact Sciences Corporation Stock Price stock today

news today EXAS – Exact Sciences Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch EXAS – Exact Sciences Corporation yahoo finance google finance

stock history EXAS – Exact Sciences Corporation invest stock market

stock prices EXAS premarket after hours

ticker EXAS fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

EXAS – Exact Sciences Corporation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: EXAS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y